CORD-19:0036b28fddf7e93da0970303672934ea2f9944e7 / 163417-163690 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1312","span":{"begin":0,"end":273},"obj":"Sentence"},{"id":"T83797","span":{"begin":0,"end":273},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Dogs diagnosed with non-gastrointestinal neoplasia and undergoing maximum-tolerated dose chemotherapy between June 2017 and January 2019 were randomised into 2 groups (\"diosmectite\" and \"standard\" groups), and were randomly re-allocated if they developed another CID event."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T664","span":{"begin":41,"end":50},"obj":"Disease"},{"id":"T93248","span":{"begin":41,"end":50},"obj":"Disease"}],"attributes":[{"id":"A664","pred":"mondo_id","subj":"T664","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A54691","pred":"mondo_id","subj":"T93248","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"Dogs diagnosed with non-gastrointestinal neoplasia and undergoing maximum-tolerated dose chemotherapy between June 2017 and January 2019 were randomised into 2 groups (\"diosmectite\" and \"standard\" groups), and were randomly re-allocated if they developed another CID event."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T443","span":{"begin":41,"end":50},"obj":"Phenotype"}],"attributes":[{"id":"A443","pred":"hp_id","subj":"T443","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Dogs diagnosed with non-gastrointestinal neoplasia and undergoing maximum-tolerated dose chemotherapy between June 2017 and January 2019 were randomised into 2 groups (\"diosmectite\" and \"standard\" groups), and were randomly re-allocated if they developed another CID event."}